Study on the effect of stopping medication in patients with dilated cardiomyopathy
Goal of this study
To study the effect of stopping medication on patients with dilated cardiomyopathy who have recovered their left ventricular function
Dilated cardiomyopathy is a condition in which the heart’s main pumping chamber, the left ventricle, becomes enlarged. This leads to a decrease in the heart’s ability to pump blood. Some patients show recovery of their left ventricular function following treatment. Thus, stopping the medication in these patients may be considered. In this study, medication will be gradually stopped in patients with dilated cardiomyopathy who have recovered their left ventricular function. The patients will be closely monitored during the process.
Who can participate in this study?
Patients who have been diagnosed dilated cardiomyopathy and who are 18 years and older may be eligible to participate in this study. This study accepts both men and women and does not accept healthy volunteers.
Important: Additional eligibility criteria apply and the patient’s record will be verified by the study doctor (with the patient’s approval) to confirm eligibility.
ClinicalTrials.gov Identifier: NCT02770443
To know if you're eligible to participate in this trial, please fill-up the form below and we will contact you shortly.